| |
        
|
|
|
 |
 |
|
You can access the latest CardioNet news via the links below.
CARDIONET BOARD OF DIRECTORS APPOINTS RANDY THURMAN CHAIRMAN, PRESIDENT AND CHIEF EXECUTIVE OFFICER
CONSHOHOCKEN, PA (BUSINESS WIRE) February 25, 2009 CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, announced today the Board of Directors has appointed Randy Thurman Chairman, President and Chief Executive Officer, effective immediately. Mr. Thurman has been serving as Chairman of the Board since June 2008 and Interim President and Chief Executive Officer since January 2009. More. . .
CARDIONET, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2008 FINANCIAL RESULTS
CONSHOHOCKEN, PA (BUSINESS WIRE) February 17, 2009 CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, today reported results for the fourth quarter and full year ended December 31, 2008. More. . .
CARDIONET, INC. TO RELEASE FOURTH QUARTER AND FULL YEAR 2008 EARNINGS RESULTS ON FEBRUARY 17, 2009
CONSHOHOCKEN, PA (BUSINESS WIRE) February 3, 2009 CardioNet, Inc. (NASDAQ:BEAT) will release its fourth quarter and full year 2008 earnings on Tuesday, February 17, 2009 at 4:00 PM, Eastern Time. More. . .
CARDIONET INVESTOR CONFERENCE CALL
CONSHOHOCKEN, PA (BUSINESS WIRE) January 26, 2009 CardioNet, Inc. (NASDAQ:BEAT) will hold an Investor Conference Call on Tuesday, January 27, 2009 at 8:30 AM Eastern Time. More. . .
CARDIONET BOARD OF DIRECTORS APPOINTS RANDY THURMAN INTERIM PRESIDENT AND CHIEF EXECUTIVE OFFICER: Reconfirms Full Year 2008 Financial Guidance; Schedules Investor Conference Call
CONSHOHOCKEN, PA (BUSINESS WIRE) January 26, 2009 CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, announced today that the Board of Directors has appointed Randy Thurman, currently the Board's Executive Chairman, as Interim President and Chief Executive Officer, effective immediately. The Board also announced that it has commenced a search for a permanent replacement for departing President and Chief Executive Officer, Arie Cohen, who has left the company to pursue other interests. More. . .
CARDIONET APPOINTS MATTHEW MARGOLIES SENIOR VICE PRESIDENT OF SALES: Former VIASYS Executive Brings Strong Sales Management Track Record and Cardiology Background
CONSHOHOCKEN, PA (BUSINESS WIRE) January 13, 2009 CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, today announced the appointment of Matthew Margolies as Senior Vice President of Sales reporting directly to Arie Cohen, President and CEO. He replaces Manny Gerolamo who has left the Company to pursue other interests. More. . .
NEW CLINICAL STUDIES SUPPORT BROADER USE OF CARDIONET SYSTEM FOR THE DETECTION OF ATRIAL FIBRILLATION: CardioNet System Recommended as Standard of Care for Post Surgical AF Ablation Home Monitoring
CONSHOHOCKEN, PA (BUSINESS WIRE) January 8, 2009 CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, today announced the publication of two studies and the presentation of two abstracts that further support the broader use of the CardioNet System for the detection of atrial fibrillation (AF). The studies demonstrate the CardioNet System's ability to detect clinically significant AF events in patients following ischemic stroke or surgical AF ablation procedures. More. . .
CARDIONET, INC. TO PRESENT AT LAZARD 5TH ANNUAL HEALTHCARE CONFERENCE
CONSHOHOCKEN, PA - (BUSINESS WIRE)- November 17, 2008 CardioNet, Inc. (NASDAQ:BEAT) announced today that Arie Cohen, President and CEO, will be presenting at the Lazard 5th Annual Healthcare Conference on Wednesday, November 19, 2008 at 2:00 PM, Eastern time, at The St. Regis Hotel, New York City, NY. More. . .
CARDIONET SYSTEM RECEIVES CATEGORY I CPT CODES AND REIMBURSEMENT RATES: Company Expects Broadened Physician Adoption and Expanded Payor Relationships
CONSHOHOCKEN, PA - (BUSINESS WIRE)- October 31, 2008 CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, today announced that the Centers for Medicare and Medicaid Services ("CMS") has established reimbursement rates that cover the CardioNet System. The reimbursement rates are applicable to the Category I CPT codes established by the American Medical Association ("AMA") and published on October 10, 2008 for Mobile Cardiovascular Telemetry. The codes and rates are contained in The Medicare Program Final Rule for the calendar year 2009 and will become effective on January 1, 2009. More. . .
CARDIONET, INC. REPORTS STRONG THIRD QUARTER 2008 RESULTS
CONSHOHOCKEN, PA - (BUSINESS WIRE)- October 30, 2008 CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, today reported results for the quarter ended September 30, 2008. More. . .
CARDIONET, INC. TO RELEASE THIRD QUARTER 2008 EARNINGS RESULTS ON OCTOBER 30, 2008
CONSHOHOCKEN, PA (BUSINESS WIRE) October 20, 2008 CardioNet, Inc. (NASDAQ:BEAT) will release its third quarter 2008 earnings on Thursday, October 30, 2008 at 4:00 PM, Eastern Time. More. . .
CARDIONET LAUNCHES ENHANCED REPORTING PACKAGE FOR THE TREATMENT OF ATRIAL FIBRILLATION
CONSHOHOCKEN, PA (BUSINESS WIRE) October 1, 2008 CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, today announced the release of its new atrial fibrillation (AF) reporting package to enhance its current AF Management Program. More. . .
CARDIONET, INC. TO PRESENT AT THOMAS WEISEL PARTNERS 2008 HEALTHCARE CONFERENCE
CONSHOHOCKEN, PA (BUSINESS WIRE) September 3, 2008 CardioNet, Inc. (NASDAQ:BEAT) announced today that Arie Cohen, President and CEO will be presenting at the Thomas Weisel Partners 2008 Healthcare Conference on Thursday, September 4, 2008 at 4:25 PM, Eastern Time, at The Four Seasons Hotel, Boston, MA. More. . .
CARDIONET ANNOUNCES HUMANA UPGRADES CARDIONET SYSTEM TO COVERED BENEFIT STATUS: Providing Access to More Than 11 Million Covered Members
CONSHOHOCKEN, PA (BUSINESS WIRE) September 3, 2008 CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, today announced that Humana, a large healthcare third-party payor, upgraded the CardioNet System to a "covered benefit" status. Previously, the CardioNet System was categorized by Humana as "experimental-investigational." More. . .
CARDIONET APPOINTS TWO DIRECTORS TO BOARD: Industry veterans bring product marketing and financial expertise to Board
CONSHOHOCKEN, PA (PRNewswire-FirstCall) August 21, 2008 CardioNet, Inc. (Nasdaq: BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, announced today that it has named Ronald Ahrens and Kirk Gorman to its Board of Directors. The appointments of Mr. Ahrens and Mr. Gorman increase CardioNet's Board to a total of nine members. More. . .
CARDIONET CORPORATE HEADQUARTERS IMPACTED BY LOCAL FIRE; PATIENT MONITORING SERVICES FULLY INTACT: Expects No Significant Disruption to Monitoring Operations
CONSHOHOCKEN, PA (BUSINESS WIRE) August 14, 2008 CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, announced that a fire which began at an adjacent new building construction site impacted its corporate headquarters and caused water and electrical damage. CardioNet's patient monitoring services remain fully intact and the Company expects no significant disruption to its patient monitoring operations. More. . .
HARRY REIN RESIGNS AS DIRECTOR OF CARDIONET
CONSHOHOCKEN, PA - (BUSINESS WIRE)- August 08, 2008 CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, today announced that Harry Rein has resigned as a director of the Company, effective August 4, 2008. Mr. Rein is a General Partner with Foundation Medical Partners L.P., which was an early investor in CardioNet, and Mr. Rein served as a director of CardioNet since January 2006. Randy Thurman, Executive Chairman of CardioNet, will serve as a member of the Audit Committee and as a member and as Chairman of the Compensation, Nominating and Corporate Governance Committee, positions formerly held by Mr. Rein. CardioNet's Board of Directors would like to thank Mr. Rein for his service and numerous contributions that have contributed to the company's success. More. . .
CARDIONET, INC. ANNOUNCES PRICING OF SECONDARY OFFERING OF COMMON STOCK
CONSHOHOCKEN, PA (BUSINESS WIRE) August 01, 2008 CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, today announced the pricing of 5,000,000 shares of outstanding common stock being offered by certain existing stockholders to the public at the price of $26.50 per share. CardioNet, Inc. will not receive any proceeds from the sale. The offer is expected to close on August 6, 2008. The selling stockholders have also granted to the underwriters a 30-day option to purchase from them an additional 750,000 shares to cover over-allotments, if any. More. . .
CARDIONET, INC. REPORTS SECOND QUARTER 2008 RESULTS
CONSHOHOCKEN, PA (BUSINESS WIRE) July 22, 2008 CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, today reported results for the quarter ended June 30, 2008. More. . .
CARDIONET ANNOUNCES PUBLIC OFFERING OF COMMON STOCK
CONSHOHOCKEN, PA (BUSINESS WIRE) July 22, 2008 CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, announced an underwritten public offering of 4,664,102 shares of common stock by certain of CardioNet's existing stockholders. The selling stockholders plan to grant to the underwriters an option to purchase from them an additional 699,615 shares to cover over-allotments, if any. CardioNet will not be selling any shares of common stock in the offering and will not receive any of the proceeds from the sale of shares by the selling stockholders. More. . .
CARDIONET, INC. TO RELEASE ITS SECOND QUARTER 2008 EARNINGS RESULTS ON JULY 22, 2008
CONSHOHOCKEN, PA (BUSINESS WIRE) July 11, 2008 CardioNet, Inc. (NASDAQ:BEAT) will release its second quarter 2008 earnings on Tuesday, July 22, 2008 at 7:00 AM Eastern Time. More. . .
CARDIONET BOARD OF DIRECTORS APPOINTS RANDY THURMAN AS EXECUTIVE CHAIRMAN: Founder Jim Sweeney Named Entrepreneur-in-Residence at University of California, San Diego (UCSD)
CONSHOHOCKEN, PA (BUSINESS WIRE) July 9, 2008 CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, announced that the Board of Directors has appointed Randy Thurman as Executive Chairman. Current Executive Chairman Jim Sweeney has accepted a position as entrepreneur-in-residence at the von Liebig Center at the University of California, San Diego. Mr. Sweeney will remain a member of the Board of Directors and expects to transition from the Board later this year.
More. . .
CARDIONET, INC. FILES RESALE REGISTRATION STATEMENT
CONSHOHOCKEN, PA - (BUSINESS WIRE)- June 23, 2008 CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, today filed a resale registration statement with the SEC related to the shares that were underlying the Mandatorily Redeemable Convertible Preferred Stock issued in March 2007. The shares being registered remain subject to lock-up agreements entered into in connection with CardioNet's IPO, pursuant to which the holders have agreed not to sell such shares until at least September 15, 2008. More. . .
CARDIONET, INC. TO PRESENT AT THE 2008 CITI INVESTMENT RESEARCH GLOBAL HEALTH CARE CONFERENCE
CONSHOHOCKEN, PA - (BUSINESS WIRE)- May 19, 2008 CardioNet, Inc. (NASDAQ:BEAT) today announced that Arie Cohen, President and Chief Executive Officer, will present at the 2008 Citi Investment Research Global Health Care Conference on Wednesday, May 21, 2008 at 2:00 PM ET at the Hilton New York in New York, NY.
More. . .
CARDIONET, INC. ANNOUNCES AMICABLE RESOLUTION OF LITIGATION
CONSHOHOCKEN, PA - (BUSINESS WIRE)- May 15, 2008 CardioNet, Inc. (NASDAQ:BEAT) announced today that LifeWatch Corp. and CardioNet have entered into a settlement agreement pursuant to which the parties have amicably agreed to resolve the lawsuit between them, with dismissal by both sides of all claims pending in the lawsuit. Terms of the agreement are confidential.
More. . .
CARDIONET, INC. REPORTS FIRST QUARTER 2008 RESULTS
CONSHOHOCKEN, PA - (BUSINESS WIRE)- April 29, 2008 CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, today reported results for the quarter ended March 31, 2008. More. . .
CARDIONET, INC. TO RELEASE ITS FIRST QUARTER 2008 EARNINGS RESULTS ON APRIL 29, 2008
CONSHOHOCKEN, PA - (BUSINESS WIRE)- April 16, 2008 CardioNet, Inc. (NASDAQ:BEAT) will release its first quarter 2008 earnings on Tuesday, April 29, 2008 at 7:00 AM, Eastern Time. More. . .
CARDIONET, INC. SETS PRICE FOR INITIAL PUBLIC OFFERING
SAN DIEGO, CA - March 19, 2008 CardioNet, Inc. announced today the initial public offering of 4,500,000 shares of common stock at a price of $18.00 per share. 3,000,000 shares are being offered by CardioNet and 1,500,000 shares are being offered by Guidant Investment Corporation. In addition, Guidant Investment Corporation has granted to the underwriters a 30-day option to purchase up to an additional 675,000 shares of common stock to cover over-allotments, if any. CardioNet common stock is expected to begin trading on the NASDAQ Global Market under the trading symbol BEAT on Wednesday, March 19, 2008. More. . .
ARRHYTHMIA DETECTION AND ALARM CONSORTIUM ESTABLISHED
SAN DIEGO, CA and GREENSBURG, PA, April 23, 2007 San Diego-based CardioNet, Inc., the leading provider of wireless mobile cardiac outpatient monitoring solutions, in partnership with Cardiac Telecom, the world pioneer of cardiac outpatient telemetry monitoring, announced today the formation of the Arrhythmia Detection and Alarm Consortium (ADAAC). More. . .
CARDIONET COMPLETES $110 MILLION IN PRIVATE FINANCING: CardioNets Equity Bridge Financing is One of the Largest in the Medical Technology Sector Since January 2000
NEW ORLEANS (ACCs Scientific Session, Booth # 4557), March 26, 2007 San Diego-based CardioNet, Inc., the leading provider of wireless mobile cardiac outpatient monitoring solutions, announced today that it has closed on $110 million in private financing, making it one of the largest private placements of equity bridge financing in the medical technology sector since January 2000, according to James M. Sweeney, CardioNets Chairman and CEO. CitiGroup Global Markets, Inc., served as the lead placement agent for this financing. Sun Trust Robinson Humphrey served as co-placement agent. More. . .
CARDIONET MOBILE CARDIAC MONITORING INNOVATOR COMPLETES ACQUISITION OF PDSHEART: Merger Creates Largest Wireless Outpatient Cardiac Monitoring Company in U.S.
PHILADELPHIA AND SAN DIEGO, March 12, 2007 San Diego-based CardioNet, Inc., a leading provider of wireless mobile cardiac outpatient monitoring solutions, announced today that it has successfully completed its acquisition of Florida-based PDSHeart, Inc., a leading cardiac event monitoring company. The terms of the acquisition were not disclosed. More. . .
NEW STUDY FINDS COMMONLY USED HEART MONITORING SYSTEM OFTEN FAILS TO DETECT SERIOUS CARDIAC ARRHYTHMIAS, A LEADING CAUSE OF STROKE AND SUDDEN CARDIAC DEATH: Multi-Center, Peer-Reviewed Study to Be Published in March Issue of Journal of Cardiovascular Electrophysiology Finds That New Methods Are Needed to Help Save Lives
PHILADELPHIA AND SAN DIEGO, March 5, 2007 A recently completed multi-center, peer-reviewed study has found that cardiac arrhythmias, one of the most common yet potentially dangerous heart conditions affecting more than four million Americans(1), often go undetected despite medical monitoring, resulting in more than 780,000 hospitalizations and contributing to approximately 500,000 deaths each year(2). More. . .
CARDIONET MOBILE CARDIAC MONITORING INNOVATOR ANNOUNCES PENDING ACQUISITION OF PDSHEART: Merger Will Create Largest Wireless Outpatient Cardiac Monitoring Company in U.S.
SAN DIEGO, CA., and WEST PALM BEACH, FL. February 6, 2007 San Diego-based CardioNet, the leading provider of wireless mobile cardiac outpatient monitoring solutions, announced today that it has reached a definitive agreement to acquire Florida-based PDSHeart, Inc., a leading cardiac event monitoring company. The acquisition is expected to close in March 2007; the terms of the agreement were not disclosed. More. . .
CARDIONET RECOGNIZED AS ONE OF 50 COMPANIES TO WATCH BY MEDICAL DEVICE
& DIAGNOSTIC INDUSTRY
PHILADELPHIA AND SAN DIEGO August 28, 2006 CardioNet, the first company to provide mobile cardiac outpatient telemetry (MCOT), has been selected by the editors of Medical Device & Diagnostic Industry (MD&DI) as one of 50 Companies to Watch. In a recent issue, companies are recognized for representing the best the industry has to offer through both their achievements in todays medical technology and contributions to the medical device and healthcare industries. More. . .
|
|
|
|
|
|
